Existing shareholder Biohaven has agreed to purchase the remaining stake in Kleo Pharmaceuticals, a Yale spinout it first backed in 2016.

The batteryless sensor producer's Fluke-led series C round closed following contributions from investors including TOP Ventures and Asahi Kasei Ventures.

Salesforce Ventures was part of a consortium that supplied $11m for the tech sales training provider in a round led by E.ventures.

Unseen Capital is targeting a $100m close for a fund that will invest in healthcare technology developers run by underrepresented founders.

Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Luba Greenwood has been brought on to run Binney Street Capital on behalf of cancer research and care provider Dana-Farber Cancer Institute.

The stem cell therapy developer has filed to go public seven months after closing $700m in funding from investors including Alphabet unit GV.

Citi Ventures has participated in the software deployment platform provider’s latest funding round, which lifted its valuation to $1.7bn.

Johnson & Johnson Innovation – JJDC co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.